Alnylam Pharmaceuticals
ALNY
#541
Rank
S$57.01 B
Marketcap
S$431.58
Share price
0.28%
Change (1 day)
14.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company